{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:57:34Z","timestamp":1792112254499,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.clinthera.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T22:46:22Z","timestamp":1381963582000},"page":"1778-1793","source":"Crossref","is-referenced-by-count":37,"title":["Guanfacine Extended Release: A Novel Treatment for Attention-Deficit\/Hyperactivity Disorder in Children and Adolescents"],"prefix":"10.1016","volume":"35","author":[{"given":"Stephen V.","family":"Faraone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"McBurnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floyd R.","family":"Sallee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Steeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.09.005_bib1","first-page":"104","article-title":"The worldwide prevalence of ADHD: is it an American condition?","volume":"2","author":"Faraone","year":"2003","journal-title":"World Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib2","first-page":"1","article-title":"Summary health statistics for US children: National Health Interview Survey, 2007","author":"Bloom","year":"2009","journal-title":"Vital Health Stat 10"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.09.005_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ambp.2006.04.011","article-title":"Peer functioning in children with ADHD","volume":"7","author":"Hoza","year":"2007","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.clinthera.2013.09.005_bib4","unstructured":"American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, Fourth Edition. Text Revision. Washington, DC: American Psychiatric Association; 2000:85\u201393."},{"key":"10.1016\/j.clinthera.2013.09.005_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0031-3955(03)00077-4","article-title":"Attention-deficit\/hyperactivity disorder evaluation and diagnosis. A practical approach in office practice","volume":"50","author":"Reiff","year":"2003","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clinthera.2013.09.005_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1037\/0022-006X.72.5.757","article-title":"Impact of executive function deficits and attention-deficit\/hyperactivity disorder (ADHD) on academic outcomes in children","volume":"72","author":"Biederman","year":"2004","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1037\/0022-006X.65.5.758","article-title":"Adolescent outcome of boys with attention-deficit\/hyperactivity disorder and social disability: results from a 4-year longitudinal follow-up study","volume":"65","author":"Greene","year":"1997","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.2007.01008.x","article-title":"Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD","volume":"116","author":"Biederman","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clinthera.2013.09.005_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1542\/peds.92.2.212","article-title":"Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey","volume":"92","author":"Barkley","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2013.09.005_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.psychres.2007.11.003","article-title":"Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records","volume":"160","author":"Mannuzza","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clinthera.2013.09.005_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S003329170500471X","article-title":"The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies","volume":"36","author":"Faraone","year":"2006","journal-title":"Psychol Med"},{"key":"10.1016\/j.clinthera.2013.09.005_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/1087054707308468","article-title":"Assessing the validity of the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form in adults with ADHD","volume":"11","author":"Mick","year":"2008","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clinthera.2013.09.005_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4088\/JCP.v67n0403","article-title":"Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community","volume":"67","author":"Biederman","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib14","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1176\/ajp.2006.163.10.1730","article-title":"Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder","volume":"163","author":"Biederman","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/87565640701729755","article-title":"Stability of executive function deficits in girls with ADHD: a prospective longitudinal followup study into adolescence","volume":"33","author":"Biederman","year":"2008","journal-title":"Dev Neuropsychol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.biopsych.2005.02.006","article-title":"Validity of the executive function theory of attention-deficit\/hyperactivity disorder: a meta-analytic review","volume":"57","author":"Willcutt","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0193-953X(03)00112-6","article-title":"Executive dysfunction in attention-deficit\/hyperactivity disorder: cognitive and neuroimaging findings","volume":"27","author":"Roth","year":"2004","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.clinthera.2013.09.005_bib18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.biopsych.2004.08.019","article-title":"Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions","volume":"57","author":"Arnsten","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.chi.0000215326.51175.eb","article-title":"The Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention-Deficit\/Hyperactivity Disorder. The Texas Children\u2019s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit\/hyperactivity disorder","volume":"45","author":"Pliszka","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2013.09.005_bib20","first-page":"S117","article-title":"New options in the pharmacological management of attention-deficit\/hyperactivity disorder","volume":"10","author":"Olfson","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2013.09.005_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","article-title":"Attention-deficit hyperactivity disorder","volume":"366","author":"Biederman","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2013.09.005_bib23","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/00004583-200202001-00003","article-title":"Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults","volume":"41","author":"Greenhill","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","article-title":"Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis","volume":"19","author":"Faraone","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib26","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","article-title":"for the SPD503 Study Group. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"121","author":"Biederman","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2013.09.005_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM199903113401007","article-title":"Treatment of attention-deficit-hyperactivity disorder","volume":"340","author":"Elia","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.09.005_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1087054707305968","article-title":"Beyond methylphenidate: nonstimulant medications for youth with ADHD","volume":"11","author":"Wood","year":"2007","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clinthera.2013.09.005_bib29","series-title":"[package insert]","author":"Adderall","year":"2011"},{"key":"10.1016\/j.clinthera.2013.09.005_bib30","series-title":"[package insert]","author":"Ritalin","year":"2010"},{"key":"10.1016\/j.clinthera.2013.09.005_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2013.09.005_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1542\/peds.2008-3347","article-title":"Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study","volume":"124","author":"Biederman","year":"2009","journal-title":"Pediatrics"},{"issue":"Suppl 11","key":"10.1016\/j.clinthera.2013.09.005_bib33","first-page":"15","article-title":"Effect of stimulant medications for attention-deficit\/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion","volume":"68","author":"Faraone","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004703-200306000-00004","article-title":"Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder","volume":"24","author":"Dosreis","year":"2003","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.clinthera.2013.09.005_bib35","first-page":"994","article-title":"Effect of stimulants on height and weight: a review of the literature","volume":"47","author":"Faraone","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib36","unstructured":"Strattera [package insert]. Indianapolis, Ind: Eli Lilly and Company; 2011."},{"key":"10.1016\/j.clinthera.2013.09.005_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","article-title":"Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response","volume":"165","author":"Newcorn","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1517\/14656566.9.9.1565","article-title":"Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit\/hyperactivity disorder","volume":"9","author":"Faraone","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2013.09.005_bib39","first-page":"S89","article-title":"Innovations in attention-deficit\/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments","volume":"10","author":"Stein","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2013.09.005_bib40","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00004583-199509000-00010","article-title":"Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette\u2019s syndrome: preliminary clinical experience","volume":"34","author":"Chappell","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004583-199501000-00013","article-title":"An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder","volume":"34","author":"Hunt","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib42","unstructured":"Shojaei AH, Chang RK, Pennick M. Guanfacine extended release tablets as treatment for attention-deficit\/hyperactivity disorder: formulation characteristics. Poster presented at: US Psychiatric & Mental Health Congress; November 16\u201319, 2006; New Orleans, La."},{"key":"10.1016\/j.clinthera.2013.09.005_bib43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1592\/phco.27.9.1253","article-title":"Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder","volume":"27","author":"Boellner","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2013.09.005_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clinthera.2007.04.016","article-title":"A Phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults","volume":"29","author":"Swearingen","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2013.09.005_bib45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2165\/00023210-200418140-00005","article-title":"New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential","volume":"18","author":"Connor","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2013.09.005_bib46","unstructured":"Intuniv [package insert]. Wayne, Pa: Shire Pharmaceuticals Inc; 2011."},{"key":"10.1016\/j.clinthera.2013.09.005_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1017\/S1092852900017107","article-title":"Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD","volume":"13","author":"Biederman","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.clinthera.2013.09.005_bib48","first-page":"755","article-title":"Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Connor","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2013.09.005_bib49","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1087054709332472","article-title":"Effects of extended-release guanfacine on ADHD symptoms and sedation-related adverse events in children with ADHD","volume":"13","author":"Faraone","year":"2009","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clinthera.2013.09.005_bib50","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.clinthera.2007.09.020","article-title":"Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years","volume":"29","author":"Kisicki","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2013.09.005_bib51","unstructured":"Turnbow JM, Kollins SH, Lopez FA, et al. Response to guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder. Poster presented at: Society of Biological Psychiatry 65th Annual Meeting; May 20\u201322, 2010; New Orleans, La."},{"key":"10.1016\/j.clinthera.2013.09.005_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CHI.0b013e318191769e","article-title":"for the SPD503 Study Group. Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: a placebo-controlled trial","volume":"48","author":"Sallee","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cap.2008.0080","article-title":"Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"19","author":"Sallee","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/cap.2008.0152","article-title":"Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"19","author":"Spencer","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaac.2011.10.012","article-title":"A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit\/hyperactivity disorder","volume":"51","author":"Wilens","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib56","doi-asserted-by":"crossref","unstructured":"Rubin J, Lopez FA, Youcha S. Impact of guanfacine extended release on cognitive problems and inattention. Poster presented at: 2010 Annual Meeting of the Society for Developmental and Behavioral Pediatrics Annual Meeting; September 11\u201314, 2010; Boston, Mass.","DOI":"10.1097\/01.DBP.0000390306.94001.58"},{"key":"10.1016\/j.clinthera.2013.09.005_bib57","unstructured":"Lopez FA, White C, Rubin J. Effects of guanfacine extended release on parent-reported behaviors in a randomized double-blind study of subjects with attention-deficit\/hyperactivity disorder. Poster presented at: American Professional Society of ADHD and Related Disorders; November 5\u20136, 2010; Washington, DC."},{"key":"10.1016\/j.clinthera.2013.09.005_bib58","first-page":"455","article-title":"The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children","volume":"26","author":"Drake","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.clinthera.2013.09.005_bib59","unstructured":"Sallee F, Wigal T, Youcha S, et al. Impact of long-term guanfacine extended release treatment on quality of life. Poster presented at: 164th Annual Meeting of the American Psychiatric Association; May 14\u201318, 2011; Honolulu, HI."},{"key":"10.1016\/j.clinthera.2013.09.005_bib60","doi-asserted-by":"crossref","unstructured":"Melmed R, Rubin J, Youcha S. Quality of life changes associated with long-term guanfacine extended release treatment. Poster presented at: 2010 Annual Meeting of the Society for Developmental and Behavioral Pediatrics; September 11\u201314, 2010; Boston, Mass.","DOI":"10.1097\/01.DBP.0000390271.72917.8e"},{"key":"10.1016\/j.clinthera.2013.09.005_bib61","unstructured":"Kollins SH, Wigal T, Vince B, et al. Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit\/hyperactivity disorder. Poster presented at: Society of Biological Psychiatry 63rd Annual Scientific Meeting; May 1\u20133, 2008; Washington, DC."},{"key":"10.1016\/j.clinthera.2013.09.005_bib62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1542\/peds.2008-1573","article-title":"Cardiovascular monitoring and stimulant drugs for attention-deficit\/hyperactivity disorder","volume":"122","author":"Perrin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2013.09.005_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000441-199001000-00016","article-title":"Guanfacine: a second generation alpha 2-adrenergic blocker","volume":"299","author":"Mosqueda-Garcia","year":"1990","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clinthera.2013.09.005_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-3955(05)70113-9","article-title":"Syncope in the pediatric patient. The cardiologist\u2019s perspective","volume":"46","author":"Lewis","year":"1999","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clinthera.2013.09.005_bib65","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(03)00127-9","article-title":"Prevalence and triggers of syncope in medical students","volume":"91","author":"Ganzeboom","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib66","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00020-X","article-title":"Syncope in children and adolescents","volume":"29","author":"Driscoll","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/mds.20738","article-title":"Syncope in children with Tourette\u2019s syndrome treated with guanfacine","volume":"21","author":"King","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2013.09.005_bib68","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1523\/JNEUROSCI.08-11-04287.1988","article-title":"The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes","volume":"8","author":"Arnsten","year":"1988","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinthera.2013.09.005_bib69","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(91)90299-6","article-title":"Delineation of rat kidney a2A- and a2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an a2A-selective compound","volume":"202","author":"Uhl\u00e9n","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib70","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1523\/JNEUROSCI.22-19-08771.2002","article-title":"Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine","volume":"22","author":"Franowicz","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinthera.2013.09.005_bib71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00003495-198631040-00003","article-title":"Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension","volume":"31","author":"Sorkin","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2013.09.005_bib72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/cap.2006.0098","article-title":"Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: emerging concepts from new data","volume":"17","author":"Arnsten","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.09.005_bib73","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuint.2009.05.014","article-title":"alpha(2)-Adrenoceptor subtypes-mediated physiological, pharmacological actions","volume":"55","author":"Gyires","year":"2009","journal-title":"Neurochem Int"},{"key":"10.1016\/j.clinthera.2013.09.005_bib74","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1996.01830050084013","article-title":"The contribution of alpha 2-noradrenergic mechanisms to prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder","volume":"53","author":"Arnsten","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2013.09.005_bib75","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","article-title":"Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex","volume":"129","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2013.09.005_bib76","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/sj.npp.1301164","article-title":"Stimulants: therapeutic actions in ADHD","volume":"31","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2013.09.005_bib77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-9081-1-2","article-title":"Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder","volume":"1","author":"Arnsten","year":"2005","journal-title":"Behav Brain Funct"},{"key":"10.1016\/j.clinthera.2013.09.005_bib78","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","article-title":"A comparison of the efficacy of medications for adult attention-deficit\/hyperactivity disorder using meta-analysis of effect sizes","volume":"71","author":"Faraone","year":"2010","journal-title":"J Clin Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813009521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813009521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T09:52:23Z","timestamp":1646819543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813009521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0149291813009521"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.09.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}